Telomir制药公司的新药物显示,有望扭转Werner综合症对动物的老化影响。 Telomir Pharmaceuticals' new drug shows promise in reversing aging effects in animals with Werner Syndrome.

Telomir制药公司报告说,其药物Telomir-1在治疗Werner综合症方面显示出可喜的成果,这是动物研究中导致快速老龄化的罕见情况。 Telomir Pharmaceuticals has reported that its drug Telomir-1 shows promising results in treating Werner Syndrome, a rare condition that causes rapid aging, in animal studies. 该药物增加了调聚物长度,恢复了身体重量和肌肉,并在受影响的动物中重新设置了老化标记。 The drug increased telomere length, restored body weight and muscle, and reset aging markers in affected animals. 它似乎有助于调节基因和重置身体的时钟,有可能减少关键系统中的功能失调。 It appears to help regulate genes and reset the body's aging clock, potentially reducing dysfunction in key systems.